Trials / Sponsors / CytoMed Therapeutics Pte Ltd
CytoMed Therapeutics Pte Ltd
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Allogeneic NKG2DL-targeting CAR γδ T Cells (CTM-N2D) in Advanced Cancers (ANGELICA) Cancer, Malignancy, Refractory Cancer | Phase 1 | 2024-11-19 |
| Unknown | Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory So Colorectal Cancer, Triple Negative Breast Cancer, Sarcoma | Phase 1 | 2019-12-01 |